Challenges to global pertussis prevention and control.
10.3760/cma.j.cn112338-20220825-00737
- Author:
Meng ZHANG
1
;
Dan WU
2
;
Yi Xing LI
2
;
Hui ZHENG
2
;
Zun Dong YIN
2
;
Xiao Feng LIANG
3
Author Information
1. School of Public Health, Shanxi Medical University, Taiyuan 030001, China.
2. National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
3. Kangtai Biological Vaccine Industry Research Institute/Disease Prevention and Control Institute of Jinan University, Guangzhou 510632, China.
- Publication Type:Journal Article
- MeSH:
Infant;
Humans;
Whooping Cough/prevention & control*;
Vaccination;
Pertussis Vaccine/therapeutic use*;
Bordetella pertussis;
Disease Outbreaks
- From:
Chinese Journal of Epidemiology
2023;44(3):491-497
- CountryChina
- Language:Chinese
-
Abstract:
Pertussis is an acute, highly infectious respiratory disease caused by Bordetella pertussis, and is one of the leading causes of infant disease and death worldwide. The pertussis vaccine has been used in the expanded program on immunization globally since 1974 and the vaccination coverage remains high. In recent years, the pertussis incidence rate increased, even pertussis outbreaks occurred, in more and more countries or areas after years with low incidence level. The disease burden of pertussis has been seriously underestimated, and the prevention and control of pertussis is facing many challenges. This article reviews the epidemic status of pertussis worldwide, the factors affecting the reemergence of pertussis, and the challenges in the prevention and control to provide a reference for prevention and control of pertussis.
